-->

Agency Responses

Agency Responses

This page contains our statements regarding the actions or inactions of various national, regional, and world public health agencies, including the FDA, NIH, WHO, etc.

Jul 8, 2022
Letter to American Board of Internal Medicine regarding ‘Notice of Potential Disciplinary Sanction’: Dr. Paul Marik
The response sent on behalf of Paul E. Marik, MD to the American Board of Internal Medicine (ABIM) letter of May 26, 2022 raising concerns that Dr. Marik is spreading medical misinformation regarding the prevention and treatment of COVID-19. The letter notes that the Notice is fatally defective because it does not comply with the ABIM’s own rules.

July 8, 2022
Letter to American Board of Internal Medicine regarding ‘Notice of Potential Disciplinary Sanction’: Dr. Pierre Kory
The response sent on behalf of Pierre Kory, MD to the American Board of Internal Medicine (ABIM) letter of May 26, 2022 raising concerns that Dr. Kory is spreading medical misinformation regarding the prevention and treatment of COVID-19. The letter notes that the Notice is fatally defective because it does not comply with the ABIM’s own rules.

Jun 27, 2022
Open letter to Publix Super Markets, Inc.
FLCCC commends the company’s decision to not offer COVID-19 vaccinations to children five and younger, which lack safety data and have possibly serious side effects.

Jun 7, 2022
Dr. Paul Marik joins lawsuit against FDA over its anti-ivermectin campaign
The federal lawsuit a federal lawsuit against the U.S. Department of Health and Human Services and the Food and Drug Administration (FDA) centers around whether the FDA can interfere with the free flow of information and assume the role of a doctor.

May 10, 2022
FLCCC Statement on California Assembly Bill 2098
The FLCCC wrote to the California Assembly’s Appropriations Committee to share its thoughts on Bill 2098, which would allow bureaucrats in Sacramento to intrude on the doctor-patient relationship and do irreparable harm to the practice of medicine.
Statement

Jan 3, 2022
FLCCC Response Letter to NY Attorney General
FLCCC responds to NY Attorney General after it begins using FLCCC Providers Directory to target providers.
Response
Exhibit

May 12, 2021
FLCCC Alliance Statement on the Irregular Actions of Public Health Agencies and the Widespread Disinformation Campaign Against Ivermectin
Awareness of ivermectin’s efficacy and its adoption by physicians worldwide to successfully treat COVID-19 have grown exponentially over the past several months. Oddly, however, even as the clinical trials data and successful ivermectin treatment experiences continue to mount…Read Full Statement

Apr 7, 2021
 Expanding Our Strategy to End The Pandemic
Dr. Pierre Kory and Dr. Colleen Aldous write that the World Health Organization and National Institutes of Health now have all the data they need to recommend ivermectin to prevent and treat COVID-19—and put an end to the pandemic.

Apr 3, 2021
 FLCCC Alliance Response to All National and International Health Agency Recommendations Against Ivermectin in COVID-19

Mar 31, 2021
 FLCCC Alliance Statement on Weak Guidance on Ivermectin from the World Health Organization
WHO ignores significant data, including several large clinical trials, while claiming insufficient evidence to recommend the use of ivermectin to prevent and treat COVID-19.

Mar 7, 2021
FLCCC Alliance Statement on Misleading FDA Guidance on Ivermectin
The FLCCC Alliance is troubled by the recently updated consumer guidance on Ivermectin from the FDA. The guidance from the FDA is misleading and has the potential to raise unwarranted concern over an important drug in the prevention and treatment of COVID-19.

Feb 28, 2021
FLCCC Alliance Response to the N.I.H. Guideline Committee Recommendation on Ivermectin use in COVID-19 dated February 11, 2021

Jan 17, 2021
 FLCCC Alliance Response to the NIH Guideline Committee Recommendation on Ivermectin use in COVID-19 dated January 14th, 2021
The FLCCC considers the Panel’s unwillingness to provide more specific guidance in support of the use of ivermectin in COVID-19 to be severely out of alignment with the known clinical, epidemiological, and observational data. Our detailed response to the Panel’s criticism of the existing evidence base […]